CABA
Cabaletta Bio, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Cabaletta Bio (CABA) Stock: Buy, Sell, or Hold?
$1.49
+0.04 (+2.41%)
â˛
5d:
+4.58%
30d:
-12.13%
90d:
-45.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
49/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.36 â $1.80
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$12.00
+727.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.18 / $1.63
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CABA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CABA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CABA is currently trading at $1.49, which is considered slightly low relative to its 30-day fair value range of $1.36 to $1.80.
Technical Outlook: Technically, CABA is in a strong downtrend. Immediate support is located at $1.18, while resistance sits at $1.63.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+727.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CABA is in a strong downtrend. Immediate support is located at $1.18, while resistance sits at $1.63.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+727.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.36 -
$1.80
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.36 -
$1.80
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.18
Resistance Level
$1.63
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 727.6% below Wall St target ($12.00)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.34
Wall Street Target
$12.00
(+727.6%)
Share CABA Analysis
Share this live CABA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CABA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
The Idiopathic Inflammatory Myositis market is projected to grow at a CAGR of 16.8% from 2026 to 2036, driven by rising demand for targeted therapies and a growing clinical development pipeline.
Key Retail Themes:
Idiopathic Inflammatory Myositis market growth
Targeted therapies and clinical development pipeline
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CABA Research Pages
